Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Free Cash Flow (2021 - 2025)

Cardio Diagnostics Holdings' Free Cash Flow history spans 5 years, with the latest figure at -$1.6 million for Q3 2025.

  • For Q3 2025, Free Cash Flow fell 31.82% year-over-year to -$1.6 million; the TTM value through Sep 2025 reached -$5.9 million, up 1.43%, while the annual FY2024 figure was -$5.2 million, 16.65% up from the prior year.
  • Free Cash Flow for Q3 2025 was -$1.6 million at Cardio Diagnostics Holdings, up from -$1.6 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$174.0 in Q3 2021 and bottomed at -$3.3 million in Q4 2022.
  • The 5-year median for Free Cash Flow is -$1.4 million (2024), against an average of -$1.3 million.
  • The largest annual shift saw Free Cash Flow crashed 798659.2% in 2022 before it soared 37.2% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$300944.0 in 2021, then plummeted by 999.52% to -$3.3 million in 2022, then surged by 32.83% to -$2.2 million in 2023, then skyrocketed by 37.2% to -$1.4 million in 2024, then fell by 11.48% to -$1.6 million in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Free Cash Flow are -$1.6 million (Q3 2025), -$1.6 million (Q2 2025), and -$1.4 million (Q1 2025).